Page last updated: 2024-10-30

labetalol and Autonomic Hyperreflexia

labetalol has been researched along with Autonomic Hyperreflexia in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Treatment with labetalol was only partially successful in controlling the elevated blood pressure."1.32Autonomic dysreflexia manifested by severe hypertension. ( Assadi, F; Czech, K; Palmisano, JL, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assadi, F1
Czech, K1
Palmisano, JL1

Other Studies

1 other study available for labetalol and Autonomic Hyperreflexia

ArticleYear
Autonomic dysreflexia manifested by severe hypertension.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:12

    Topics: Adult; Antihypertensive Agents; Autonomic Dysreflexia; Blood Pressure; Drainage; Humans; Hypertensio

2004